ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | -98.3% | 300 | -98.9% | 0.00% | -97.1% |
| Q2 2017 | $234,000 | -43.8% | 28,000 | -39.8% | 0.03% | -29.2% |
| Q1 2017 | $416,000 | +105.9% | 46,526 | -2.9% | 0.05% | +92.0% |
| Q4 2015 | $202,000 | +42.3% | 47,900 | +54.0% | 0.02% | +56.2% |
| Q3 2015 | $142,000 | -75.8% | 31,100 | -61.7% | 0.02% | -79.5% |
| Q2 2015 | $586,000 | – | 81,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |